Athyrium Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Athyrium Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,857,268	Closed	-$129M	–	8
2023 Q1	$129M	Hold	8,857,268	–	–	46.27%	1
2022 Q4	$64.7M	Hold	8,857,268	–	–	27.18%	1
2022 Q3	$61.3M	Hold	8,857,268	–	–	22.96%	2
2022 Q2	$61.9M	Hold	8,857,268	–	–	26.04%	2
2022 Q1	$73.3M	Hold	8,857,268	–	–	26.04%	2
2021 Q4	$95.7M	Buy	8,857,268 +4,337,268	+96%	+$46.8M	34.1%	1
2021 Q3	$54.4M	Hold	4,520,000	–	–	34.53%	2
2021 Q2	$54.8M	Hold	4,520,000	–	–	22.86%	2
2021 Q1	$63M	Hold	4,520,000	–	–	31.84%	2
2020 Q4	$64M	Buy	+4,520,000	New	+$59M	30.84%	2

Athyrium Capital Management's AMYT Position: Q2 2023 in Review

Athyrium Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 8,857,268 shares — an estimated $129M sold.

Athyrium Capital Management first reported a position in AMYT in Q4 2020 and held it in 10 quarters. The position peaked at $129M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Athyrium Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Athyrium Capital Management sold 8,857,268 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $129M.
Athyrium Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2020 and held it in 10 quarters.
Athyrium Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $129M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Athyrium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.